At eN-RAMPS, we do not just develop novel science; we engineer the platforms that make novel science commercially viable. The greatest bottleneck in chemical and biopharmaceutical manufacturing is the transition from laboratory proof-of-concept to industrial scale. We solve this. By building automated, high-throughput microfluidic screening platforms and pilot-scale electrochemical reactors, we systematically de-risk the scaling process for solid form crystallization, lipid nanoparticle formulation, and chemical synthesis. Our projects are active, deployable assets designed to drastically reduce R&D timelines, secure robust intellectual property, and provide our partners with an unparalleled speed-to-market advantage.